Aviva (AV) Shares: Motor Cover, Pensions and Wealth Platforms

Aviva plc (AV) is one of the few British companies that sells both the insurance policy on your car and the pension that will pay you in retirement. That breadth is the starting point for any serious Aviva share price analysis, because the group is really three businesses bolted together: a large general insurer writing motor and home cover in the UK, Ireland and Canada; a life, protection and retirement arm that collects premiums and manages long-term savings; and a fast-growing wealth platform. Each earns money in a different way, each consumes capital differently, and the shares behave according to the blend. This article walks through how that blend works, what the most recent reported numbers show, and which measures track delivery against what has been promised.

An Aviva share price analysis begins with the business mix

Aviva reports through five segments: Insurance, Wealth and Retirement (IWR) in the UK; UK and Ireland General Insurance; Canada General Insurance; Aviva Investors, its asset management arm; and International. The company describes itself as the UK's leading diversified insurer rather than simply the largest, and the detail behind that matters. It is the largest life insurer in the UK with roughly a quarter of that market, the leading general insurer in the UK, and the second-largest general insurer in Canada. Its 2024 annual report put the customer base at 20.5 million across the UK, Ireland and Canada.

The economics of those two halves are not the same. General insurance is an annual contract: Aviva takes a premium, pays claims and expenses, and keeps the difference. The measure that captures it is the combined operating ratio: claims and expenses as a percentage of premiums. Anything below 100% means the underwriting itself made money before investment returns are counted. Life, protection and retirement work on a longer clock. Aviva writes business today that releases profit and capital over decades, so the headline accounting profit tells you less than the cash the subsidiaries actually remit to the centre and the capital they free up as old books run off.

Wealth sits somewhere between the two. Aviva runs workplace pension schemes and an adviser platform, charging a fee on assets it administers rather than taking underwriting risk. That is the capital-light end of the business, and management has been explicit about wanting more of it: the stated ambition is for 75% of group earnings to be capital-light by 2028. Investors comparing Aviva with pure life insurers such as Legal and General (LGEN) or Phoenix Group (PHNX), or with pure general insurers such as Admiral Group (ADM), are really comparing different points on that spectrum.

What the H1 2026 results showed

Aviva reports on a half-year and full-year basis rather than quarterly, with light trading updates in between. Its H1 2026 results, published on 14 August 2026, were the strongest first half the group has recorded under its current structure.

• Group operating profit of £1,326m, up 24% from £1,068m in H1 2025.
• Operating earnings per share of 31.8p, up 10% — a slower rate than profit because the share count rose to fund an acquisition.
• IFRS return on equity of 20.3%, against 18.2% in the prior half.
• Cash remittances from the operating subsidiaries to the holding company of £1,498m, up 47%.
• UK and Ireland general insurance operating profit of £643m, up 50%, with a combined operating ratio of 93.3%.
• Wealth operating profit of £102m, up 34%.

One figure runs the other way and is worth understanding rather than ignoring. IFRS profit for the period fell 49% to £418m, with basic earnings per share down 44% to 12.2p. That is not a contradiction of the operating numbers. Operating profit strips out short-term investment variances, integration costs and other items that management treats as outside the underlying run rate; IFRS profit includes them. For a life insurer holding large bond portfolios against long-dated liabilities, the gap between the two can be wide in any given period and says more about market movements and one-off charges than about the trading performance. Both numbers are real, and a reader doing their own Aviva share price analysis should look at the reconciliation rather than picking whichever headline suits.

Direct Line reshaped the general insurance arm

The single largest change to Aviva in recent years was the £3.7bn acquisition of Direct Line, completed on 1 July 2025 through a court-approved scheme of arrangement. It made Aviva the biggest motor and home insurer in the UK, and because general insurance renews annually the effect showed up quickly.

In FY2025, reported on 5 March 2026, Direct Line contributed £174m of the group's operating profit. Strip it out and underlying growth was 15% rather than the reported 25%. The integration has run ahead of the original plan. Aviva initially targeted £125m of annual run-rate cost savings; by its Q3 2025 update it had raised that to £225m, expected by 2028, and the H1 2026 statement confirmed £100m of run-rate savings already achieved, delivered ahead of schedule. Integration costs have also risen, to roughly £350m against an original expectation of around £250m.

Alongside the cost savings sit capital synergies, which matter more than they sound. Two insurers holding separate capital buffers against partly overlapping risks need less capital combined than apart. Aviva has targeted at least £500m of such synergies, expected around the end of 2026, and at the half year said more than £350m of that remained subject to regulatory approval. That approval is a genuine gating item rather than a formality, and it is one of the clearer things to watch in the next set of results.

Solvency II, cash and the dividend

For a UK insurer, the regulatory capital position is not a footnote — it determines how much can be paid out. Aviva reports a Solvency II shareholder cover ratio, which expresses eligible own funds as a percentage of the capital the regulator requires. A ratio of 100% means the minimum is exactly met; insurers run well above that.

Aviva ended 2025 at 180%, down from 203% a year earlier, with a surplus of £7.1bn — a fall the company had guided for, reflecting the capital deployed on Direct Line. At 30 June 2026 the ratio stood at 176%, towards the upper end of the group's stated working range, and management expects it to recover to the high 180s by the year end as the remaining Direct Line capital synergies clear regulatory approval. Solvency II debt leverage was 30.1% at the 2025 year end.

The dividend has risen alongside. Aviva paid 13.1p as its 2025 interim and 26.2p as its final, taking the 2025 total to 39.3p per share against 35.7p for 2024. The 2025 increase included an extra 5% uplift on completion of the Direct Line transaction. The 2026 interim was lifted 7% to 14.0p, at a cash cost of around £420m. Guidance from 2026 onwards is for mid-single-digit growth in the cash cost of the dividend — note the wording: the commitment is to the total cash paid, not to a fixed pence-per-share increase, which gives management room to manage the payout against the share count.

A data-provider snapshot dated 12 October 2026 had the shares at 687.40p, which is £6.87 rather than £687 — LSE prices are quoted in pence, and the distinction is the difference between a sensible number and one wrong by a factor of a hundred. The same snapshot showed a trailing price-to-earnings ratio of about 14.2 and a dividend yield of roughly 6.7%. A price-to-earnings ratio divides the share price by earnings per share, so it tells you how many years of current earnings the market is paying for; for an insurer it is sensitive to which earnings measure is used, given the operating-versus-IFRS gap described above. The dividend yield is simply the annual dividend as a percentage of the price. Both are readings, not judgements, and both move daily.

Wealth, protection and the capital-light ambition

The clearest structural growth in the group is in Wealth. Net flows in H1 2026 rose 32% to £7.6bn from £5.8bn, and assets under management grew 25% to £261bn from £209bn. Aviva attributed much of that to its Workplace business, helped by the onboarding of initial transfers from the Mercer Master Trust, and to continued strength on its adviser platform. Because this is fee income on administered assets, it consumes little capital and scales with markets and with the UK's auto-enrolment pension flows.

Protection — life, critical illness and income cover sold largely through advisers — has also grown, and it is the kind of business that produces predictable cash over long periods. Health is the weaker spot: new business sales there fell 33% in the half, a reminder that not every line is pulling in the same direction.

Management's three-year targets, running to 2028, are framed per share and on returns rather than on absolute profit: an operating earnings-per-share compound annual growth rate of 11% across 2025 to 2028, an IFRS return on equity above 20% by 2028, and cumulative cash remittances of more than £7bn across 2026 to 2028. That framing matters, because it is harder to flatter with acquisitions than an absolute profit target. The previous 2026 targets of £2bn operating profit and £1.8bn of Solvency II operating own funds generation were both met a year early, in 2025, when own funds generation came in at £2,317m, up 40%.

Risks and what would change the picture

Several things could move the numbers meaningfully in either direction, and they are worth holding in view.

• Motor pricing. UK motor insurance is competitive and cyclical. Aviva is now far more exposed to it, so a period of falling premium rates against persistent claims inflation would show up directly in the combined operating ratio.
• Integration execution. The £225m cost synergy target runs to 2028 and integration costs have already overrun. Delivery, not the target, is what counts.
• Capital synergy approval. More than £350m of the Direct Line capital benefit still needs regulatory sign-off. Delay would hold the Solvency II ratio lower for longer.
• Interest rates and markets. Rates affect the discounting of long-dated liabilities, the investment return on the general insurance float, and — through asset values — the fee base in Wealth. The IFRS result is particularly sensitive here.
• Weather and large losses. Storms and floods in the UK, Ireland and Canada hit general insurance results in a way pricing discipline cannot fully smooth.
• Bulk annuity competition. Aviva competes for pension risk transfer deals against Legal and General (LGEN), Phoenix Group (PHNX) and others. Pricing discipline in that market determines whether volume is worth having.

What to watch from here

Aviva today is a business that has used a large acquisition to deepen its position in UK general insurance while simultaneously growing a capital-light wealth arm, and the FY2026 results due early in 2027 will be the first clean annual look at the combined group. The specific items that would change the picture are reasonably well defined: whether the Solvency II cover ratio recovers to the high 180s as guided once the remaining capital synergies are approved; whether the £225m cost synergy run rate keeps arriving ahead of schedule; whether Wealth net flows hold near the pace set in the first half; whether the UK and Ireland combined operating ratio stays in the low 90s as motor pricing moves through its cycle; and whether operating earnings per share tracks the 11% compound growth the three-year targets require.

Equally, the gap between operating and IFRS profit, the trajectory of integration costs, and the direction of Health new business are the places where strain would appear first. None of these figures settles the question of what the shares are worth — that depends on assumptions about rates, claims and flows that reasonable people weigh differently. What they do is give a reader running their own Aviva share price analysis a defined set of numbers to check at each reporting date, and a clear sense of which ones actually carry the story.